Referencias

Artículos clave

Institute for Clinical Systems Improvement. Depression, adult in primary care. March 2016 [internet publication].Texto completo external link opens in a new window

Qaseem A, Barry MJ, Kansagara D, et al. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Mar 1;164(5):350-9.Texto completo external link opens in a new windowResumen external link opens in a new window

Woltmann E, Grogan-Kaylor A, Perron B, et al. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012 Aug;169(8):790-804.Texto completo external link opens in a new windowResumen external link opens in a new window

Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005 Oct 26;294(16):2064-74.Resumen external link opens in a new window

Bauer M, Severus E, Köhler S, et al; World Federation of Societies of Biological Psychiatry Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder - update 2015. World J Biol Psychiatry. 2015 Feb;16(2):76-95.Texto completo external link opens in a new windowResumen external link opens in a new window

Spielmans GI, Berman MI, Linardatos E, et al. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013;10(3):e1001403.Texto completo external link opens in a new windowResumen external link opens in a new window

Artículos de referencia

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

2. Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001 Sep-Oct;50(5):275-85.Resumen external link opens in a new window

3. O'Connor E, Rossom RC, Henninger M, et al. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Jan 26;315(4):388-406.Resumen external link opens in a new window

4. Institute for Clinical Systems Improvement. Depression, adult in primary care. March 2016 [internet publication].Texto completo external link opens in a new window

5. Carney RM, Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol. 2016 Nov 17;14(3):145-55.Texto completo external link opens in a new windowResumen external link opens in a new window

6. Robinson RG, Jorge RE. Post-stroke depression: a review. Am J Psychiatry. 2015 Dec 18;173(3):221-31.Texto completo external link opens in a new windowResumen external link opens in a new window

7. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015 May 17;3(6):461-71.Resumen external link opens in a new window

8. Caruso R, Nanni MG, Riba M, et al. Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol. 2017 Feb;56(2):146-55.Resumen external link opens in a new window

9. World Health Organization. Depression and other common mental disorders: global health estimates. 2017 [internet publication].Texto completo external link opens in a new window

10. Qaseem A, Barry MJ, Kansagara D, et al. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Mar 1;164(5):350-9.Texto completo external link opens in a new windowResumen external link opens in a new window

11. Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002 Nov 26;167(11):1253-60.Resumen external link opens in a new window

12. Shim RS, Baltrus P, Ye J, et al. Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008. J Am Board Fam Med. 2011 Jan-Feb;24(1):33-8.Texto completo external link opens in a new windowResumen external link opens in a new window

13. Pedersen CB, Mors O, Bertelsen A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014 May;71(5):573-81.Texto completo external link opens in a new windowResumen external link opens in a new window

14. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 2009 Jun 17;301(23):2462-71.Resumen external link opens in a new window

15. Wang Q, Shelton RC, Dwivedi Y. Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: a systematic review and meta-analysis. J Affect Disord. 2018 Jan 1;225:422-8.Texto completo external link opens in a new windowResumen external link opens in a new window

16. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007 Mar;64(3):327-37.Resumen external link opens in a new window

17. Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry. 2006;67(suppl 6):S46-9.Resumen external link opens in a new window

18. Greden JF. Physical symptoms of depression: unmet needs. J Clin Psychiatry. 2003;64(suppl 7):S5-11.Resumen external link opens in a new window

19. Ising M, Horstmann S, Kloiber S, et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol Psychiatry. 2007 Jul 1;62(1):47-54.Resumen external link opens in a new window

20. Schmaal L, Hibar DP, Sämann PG, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017 Jun;22(6):900-9. Texto completo external link opens in a new windowResumen external link opens in a new window

21. Schmaal L, Veltman DJ, van Erp TG, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016 Jun;21(6):806-12.Texto completo external link opens in a new windowResumen external link opens in a new window

22. MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry. 2011 Mar;16(3):252-64.Texto completo external link opens in a new windowResumen external link opens in a new window

23. Peng W, Chen Z, Yin L, et al. Essential brain structural alterations in major depressive disorder: a voxel-wise meta-analysis on first episode, medication-naive patients. J Affect Disord. 2016 Jul 15;199:114-23.Resumen external link opens in a new window

24. Zhong X, Pu W, Yao S. Functional alterations of fronto-limbic circuit and default mode network systems in first-episode, drug-naïve patients with major depressive disorder: a meta-analysis of resting-state fMRI data. J Affect Disord. 2016 Dec;206:280-6. Resumen external link opens in a new window

25. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry. 2003 Aug 1;54(3):363-75.Resumen external link opens in a new window

26. Gavin NI, Gaynes BN, Lohr KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005 Nov;106(5 Pt 1):1071-83.Resumen external link opens in a new window

27. Barlow J, Smailagic N, Huband N, et al. Group-based parent training programmes for improving parental psychosocial health. Cochrane Database Syst Rev. 2014 May 17;(5):CD002020.Texto completo external link opens in a new windowResumen external link opens in a new window

28. Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry. 1999 Apr;56(4):322-7.Resumen external link opens in a new window

29. Runeson B, Asberg M. Family history of suicide among suicide victims. Am J Psychiatry. 2003 Aug;160(8):1525-6.Resumen external link opens in a new window

30. Baraldi S, Hepgul N, Mondelli V, et al. Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review. J Clin Psychopharmacol. 2012 Aug;32(4):531-43.Resumen external link opens in a new window

31. Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer. BMJ. 2018 Apr 25;361:k1415.Texto completo external link opens in a new windowResumen external link opens in a new window

32. Nanni MG, Caruso R, Mitchell AJ, et al. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015 Jan;17(1):530.Resumen external link opens in a new window

33. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003 Nov 10;163(20):2433-45.Texto completo external link opens in a new windowResumen external link opens in a new window

34. Pereira-Miranda E, Costa PRF, Queiroz VAO, et al. Overweight and obesity associated with higher depression prevalence in adults: a systematic review and meta-analysis. J Am Coll Nutr. 2017 Mar-Apr;36(3):223-33.Resumen external link opens in a new window

35. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7-23.Texto completo external link opens in a new windowResumen external link opens in a new window

36. Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017 May 1;32(5):1075-91.Texto completo external link opens in a new windowResumen external link opens in a new window

37. Secinti E, Thompson EJ, Richards M, et al. Research Review: childhood chronic physical illness and adult emotional health - a systematic review and meta-analysis. J Child Psychol Psychiatry. 2017 Jul;58(7):753-69.Resumen external link opens in a new window

38. Kool S, Schoevers R, de Maat S, et al. Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. J Affect Disord. 2005 Nov;88(3):269-78.Resumen external link opens in a new window

39. Goodarzi ZS, Mele BS, Roberts DJ, et al. Depression case finding in individuals with dementia: a systematic review and meta-analysis. J Am Geriatr Soc. 2017 May;65(5):937-48.Resumen external link opens in a new window

40. Mitchell AJ, Yadegarfar M, Gill J, et al. Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies. BJPsych Open. 2016 Mar 9;2(2):127-38.Texto completo external link opens in a new windowResumen external link opens in a new window

41. Di Florio A, Putnam K, Altemus M, et al. The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. Psychol Med. 2017 Apr;47(5):787-99. Texto completo external link opens in a new windowResumen external link opens in a new window

42. Wisner KL, Parry BL, Piontek CM. Clinical practice. Postpartum depression. N Engl J Med. 2002 Jul 18;347(3):194-9.Resumen external link opens in a new window

43. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6.Resumen external link opens in a new window

44. Sheikh JI, Yesavage JA, Brooks JO, 3rd, et al. Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr. 1991 Spring;3(1):23-8.Resumen external link opens in a new window

45. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-1983;17(1):37-49.Resumen external link opens in a new window

46. Alexopoulos GS, Abrams RC, Young RC, et al. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988 Feb 1;23(3):271-84.Resumen external link opens in a new window

47. Morris DW, Trivedi MH, Rush AJ. Folate and unipolar depression. J Altern Complement Med. 2008 Apr;14(3):277-85.Resumen external link opens in a new window

48. Casarett D, Kutner JS, Abrahm J. Life after death: a practical approach to grief and bereavement. Ann Intern Med. 2001;134:208-215.Resumen external link opens in a new window

49. Shear MK, Wang Y, Skritskaya N, et al. Treatment of complicated grief in elderly persons: a randomized clinical trial. JAMA Psychiatry. 2014 Nov;71(11):1287-95.Texto completo external link opens in a new windowResumen external link opens in a new window

50. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98.Resumen external link opens in a new window

51. Zbozinek TD, Rose RD, Wolitzky-Taylor KB, et al. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depress Anxiety. 2012 Dec;29(12):1065-71.Texto completo external link opens in a new windowResumen external link opens in a new window

52. Moyer VA; Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: US preventive services task force recommendation statement. Ann Intern Med. 2013 Aug 6;159(3):210-8.Texto completo external link opens in a new windowResumen external link opens in a new window

53. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005 Jun;24(2):92-102.Resumen external link opens in a new window

54. Povitz M, Bolo CE, Heitman SJ, et al. Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLoS Med. 2014 Nov 25;11(11):e1001762.Texto completo external link opens in a new windowResumen external link opens in a new window

55. National Institute for Health and Care Excellence. Depression in adults: recognition and management. April 2018 [internet publication].Texto completo external link opens in a new window

56. Siu AL; US Preventive Services Task Force (USPSTF), Bibbins-Domingo K, et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016 Jan 26;315(4):380-7.Texto completo external link opens in a new windowResumen external link opens in a new window

57. Canadian Task Force on Preventive Health Care; Joffres M, Jaramillo A, Dickinson J, et al. Recommendations on screening for depression in adults. CMAJ. 2013 Jun 11;185(9):775-82.Texto completo external link opens in a new windowResumen external link opens in a new window

58. Hofmann SG, Curtiss J, Carpenter JK, et al. Effect of treatments for depression on quality of life: a meta-analysis. Cogn Behav Ther. 2017 Jun;46(4):265-86. Texto completo external link opens in a new windowResumen external link opens in a new window

59. Lee Y, Rosenblat JD, Lee J, et al. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: a systematic review. J Affect Disord. 2018 Feb;227:406-15.Resumen external link opens in a new window

60. Barbui C, Butler R, Cipriani A, et al. Depression in adults. BMJ Clinical Evid, Issue 16, 2006.Texto completo external link opens in a new window

61. Woltmann E, Grogan-Kaylor A, Perron B, et al. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012 Aug;169(8):790-804.Texto completo external link opens in a new windowResumen external link opens in a new window

62. Richards DA, Hill JJ, Gask L, et al. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ. 2013 Aug 19;347:f4913.Texto completo external link opens in a new windowResumen external link opens in a new window

63. Panagioti M, Bower P, Kontopantelis E, et al. Association between chronic physical conditions and the effectiveness of collaborative care for depression: an individual participant data meta-analysis. JAMA Psychiatry. 2016 Sep 1;73(9):978-89.Resumen external link opens in a new window

64. Overbeck G, Davidsen AS, Kousgaard MB. Enablers and barriers to implementing collaborative care for anxiety and depression: a systematic qualitative review. Implement Sci. 2016 Dec 28;11(1):165.Texto completo external link opens in a new windowResumen external link opens in a new window

65. Josephine K, Josefine L, Philipp D, et al. Internet- and mobile-based depression interventions for people with diagnosed depression: a systematic review and meta-analysis. J Affect Disord. 2017 Dec 1;223:28-40.Resumen external link opens in a new window

66. Păsărelu CR, Andersson G, Bergman Nordgren L, et al. Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials. Cogn Behav Ther. 2017 Jan;46(1):1-28. Resumen external link opens in a new window

67. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005 Oct 26;294(16):2064-74.Resumen external link opens in a new window

68. Vaiva G, Vaiva G, Ducrocq F, et al. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006 May 27;332(7552):1241-5.Resumen external link opens in a new window

69. Wijkstra J, Lijmer J, Burger H, et al. Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev. 2015 Jul 30;(7):CD004044.Texto completo external link opens in a new windowResumen external link opens in a new window

70. Geduldig ET, Kellner CH. Electroconvulsive therapy in the elderly: new findings in geriatric depression. Curr Psychiatry Rep. 2016 Apr;18(4):40.Resumen external link opens in a new window

71. Watts BV, Groft A, Bagian JP. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT. 2011 Jun;27(2):105-8.Resumen external link opens in a new window

72. Tørring N, Sanghani SN, Petrides G, et al. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatr Scand. 2017 May;135(5):388-97.Resumen external link opens in a new window

73. Rose D, Fleischmann P, Wykes T, et al. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ. 2003 Jun 21;326(7403):1363.Resumen external link opens in a new window

74. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010 Sep 15;68(6):568-77.Resumen external link opens in a new window

75. Gibbons RD, Hur K, Brown CH, et al. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 Jun;69(6):572-9.Texto completo external link opens in a new windowResumen external link opens in a new window

76. Vöhringer PA, Ghaemi SN. Solving the antidepressant efficacy question: effect sizes in major depressive disorder. Clin Ther. 2011 Dec;33(12):B49-61.Texto completo external link opens in a new windowResumen external link opens in a new window

77. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Apr 7;391(10128):1357-66.Texto completo external link opens in a new windowResumen external link opens in a new window

78. Oestergaard S, Møldrup C. Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: a meta-analysis. J Affect Disord. 2011 Jun;131(1-3):24-36.Resumen external link opens in a new window

79. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 2011 Dec 6;155(11):772-85.Texto completo external link opens in a new windowResumen external link opens in a new window

80. Thase ME, Nierenberg AA, Vrijland P, et al. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol. 2010 Jul;25(4):189-98.Resumen external link opens in a new window

81. Peterson K, Dieperink E, Anderson J, et al. Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder. Psychopharmacology (Berl). 2017 Jun;234(11):1649-61.Resumen external link opens in a new window

82. Rucci P, Frank E, Scocco P, et al. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial. Depress Anxiety. 2011 Apr;28(4):303-9.Texto completo external link opens in a new windowResumen external link opens in a new window

83. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004 Jul 21;292(3):338-43.Texto completo external link opens in a new windowResumen external link opens in a new window

84. Miller M, Swanson SA, Azrael D, et al. Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med. 2014 Jun;174(6):899-909.Texto completo external link opens in a new windowResumen external link opens in a new window

85. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA's safety review. BMJ. 2005 Feb 19;330(7488):385.Resumen external link opens in a new window

86. Saperia J, Ashby D, Gunnell D. Suicidal behaviour and SSRIs: updated meta-analysis. BMJ. 2006 Jun 17;332(7555):1453.Resumen external link opens in a new window

87. Näslund J, Hieronymus F, Lisinski A,et al. Effects of selective serotonin reuptake inhibitors on rating-scale-assessed suicidality in adults with depression. Br J Psychiatry. 2018 Mar;212(3):148-54.Resumen external link opens in a new window

88. Dold M, Bartova L, Rupprecht R, et al. Dose escalation of antidepressants in unipolar depression: a meta-analysis of double-blind, randomized controlled trials. Psychother Psychosom. 2017 Sep 14;86(5):283-91.Resumen external link opens in a new window

89. McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry. 2006 Sep;163(9):1531-41.Texto completo external link opens in a new windowResumen external link opens in a new window

90. Schlaepfer TE, Agren H, Monteleone P, et al. The hidden third: improving outcome in treatment-resistant depression. J Psychopharmacol. 2012 May;26(5):587-602.Resumen external link opens in a new window

91. Kemp DE, Ganocy SJ, Brecher M, et al. Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. J Affect Disord. 2011 Apr;130(1-2):171-9.Resumen external link opens in a new window

92. Lam RW. Onset, time course and trajectories of improvement with antidepressants. Eur Neuropsychopharmacol. 2012;22(suppl 3):S492-8.Resumen external link opens in a new window

93. Wagner S, Engel A, Engelmann J, et al. Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with major depressive disorder: systematic review and meta-analysis. J Psychiatr Res. 2017 Nov;94:96-106.Resumen external link opens in a new window

94. Olgiati P, Serretti A, Souery D, et al. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression. J Affect Disord. 2018 Feb;227:777-86.Resumen external link opens in a new window

95. Posternak MA, Baer L, Nierenberg AA, et al. Response rates to fluoxetine in subjects who initially show no improvement. J Clin Psychiatry. 2011 Jul;72(7):949-54.Resumen external link opens in a new window

96. Baldessarini RJ, Lau WK, Sim J, et al. Duration of initial antidepressant treatment and subsequent relapse of major depression. J Clin Psychopharmacol. 2015 Feb;35(1):75-6.Resumen external link opens in a new window

97. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003 Feb 22;361(9358):653-61.Resumen external link opens in a new window

98. El-Mallakh RS, Briscoe B. Studies of long-term use of antidepressants: how should the data from them be interpreted? CNS Drugs. 2012 Feb 1;26(2):97-109.Resumen external link opens in a new window

99. Bauer M, Severus E, Köhler S, et al; World Federation of Societies of Biological Psychiatry Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder - update 2015. World J Biol Psychiatry. 2015 Feb;16(2):76-95.Texto completo external link opens in a new windowResumen external link opens in a new window

100. Health Quality Ontario. Psychotherapy for major depressive disorder and generalized anxiety disorder: a health technology assessment. Ont Health Technol Assess Ser. 2017 Nov 13;17(15):1-167.Texto completo external link opens in a new windowResumen external link opens in a new window

101. Karyotaki E, Smit Y, de Beurs DP, et al. The long-term efficacy of acute-phase psychotherapy for depression: a meta-analysis of randomized trials. Depress Anxiety. 2016 May;33(5):370-83.Resumen external link opens in a new window

102. Furukawa TA, Weitz ES, Tanaka S, et al. Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry. 2017 Mar;210(3):190-6.Resumen external link opens in a new window

103. Gartlehner G, Wagner G, Matyas N, et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open. 2017 Jun 14;7(6):e014912.Texto completo external link opens in a new windowResumen external link opens in a new window

104. Kuyken W, Hayes R, Barrett B, et al. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015 Jul 4;386(9988):63-73.Texto completo external link opens in a new windowResumen external link opens in a new window

105. Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 2016 Feb 1;173(2):128-37.Texto completo external link opens in a new windowResumen external link opens in a new window

106. Bockting CLH, Klein NS, Elgersma HJ, et al. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial. Lancet Psychiatry. 2018 May;5(5):401-10.Resumen external link opens in a new window

107. Kuyken W, Warren FC, Taylor RS, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry. 2016 Jun 1;73(6):565-74.Resumen external link opens in a new window

108. Wiles N, Thomas L, Abel A, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014 May;18(31):1-167.Texto completo external link opens in a new windowResumen external link opens in a new window

109. Cuijpers P, Geraedts AS, van Oppen P, et al. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychiatry. 2011 Jun;168(6):581-92.Texto completo external link opens in a new windowResumen external link opens in a new window

110. Bell AC, D'Zurilla TJ. Problem-solving therapy for depression: a meta-analysis. Clin Psychol Rev. 2009 Jun;29(4):348-53.Resumen external link opens in a new window

111. Kirkham JG, Choi N, Seitz DP. Meta-analysis of problem solving therapy for the treatment of major depressive disorder in older adults. Int J Geriatr Psychiatry. 2016 May;31(5):526-35.Resumen external link opens in a new window

112. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005 Apr;62(4):417-22.Resumen external link opens in a new window

113. De Mello MF, De Jesus Mari J, Bacaltchuk J, et al. A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. Eur Arch Psychiatry Clin Neurosci. 2005 Apr;255(2):75-82.Resumen external link opens in a new window

114. Cuijpers P, van Straten A, Warmerdam L. Problem solving therapies for depression: a meta-analysis. Eur Psychiatry. 2007 Jan;22(1):9-15.Resumen external link opens in a new window

115. Gualano MR, Bert F, Martorana M, et al. The long-term effects of bibliotherapy in depression treatment: systematic review of randomized clinical trials. Clin Psychol Rev. 2017 Dec;58:49-58.Resumen external link opens in a new window

116. Richards DA, Ekers D, McMillan D, et al. Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet. 2016 Aug 27;388(10047):871-80.Texto completo external link opens in a new windowResumen external link opens in a new window

117. Gartlehner G, Gaynes BN, Amick HR, et al. Comparative benefits and harms of antidepressant, psychological, complementary, and exercise treatments for major depression: an evidence report for a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Mar 1;164(5):331-41.Resumen external link opens in a new window

118. Cuijpers P, van Straten A, van Schaik A, et al. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract. 2009 Feb;59(559):e51-60.Texto completo external link opens in a new windowResumen external link opens in a new window

119. Cuijpers P, van Straten A, Andersson G, et al. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008 Dec;76(6):909-22.Resumen external link opens in a new window

120. Cuijpers P, van Straten A, Warmerdam L, et al. Psychological treatment of depression: a meta-analytic database of randomized studies. BMC Psychiatry. 2008 May 16;8:36.Texto completo external link opens in a new windowResumen external link opens in a new window

121. Aalbers S, Fusar-Poli L, Freeman RE, et al. Music therapy for depression. Cochrane Database Syst Rev. 2017 Nov 16;(11):CD004517.Texto completo external link opens in a new windowResumen external link opens in a new window

122. Even C, Schröder CM, Friedman S, et al. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord. 2008 May;108(1-2):11-23.Resumen external link opens in a new window

123. Penders TM, Stanciu CN, Schoemann AM, et al. Bright light therapy as augmentation of pharmacotherapy for treatment of depression: a systematic review and meta-analysis. Prim Care Companion CNS Disord. 2016 Oct 20;18(5).Resumen external link opens in a new window

124. Morgan, AJ, Jorm AF. Self-help interventions for depressive disorders and depressive symptoms: a systematic review. Ann Gen Psychiatry. 2008 Aug 19;7:13.Texto completo external link opens in a new windowResumen external link opens in a new window

125. Sun YL, Chen SB, Gao Y, et al. Acupuncture versus western medicine for depression in China: a systematic review. Chin J Evid Based Med. 2008;8:340-5.

126. Herring MP, Puetz TW, O'Connor PJ, et al. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2012 Jan 23;172(2):101-11.Texto completo external link opens in a new windowResumen external link opens in a new window

127. Chi I, Jordan-Marsh M, Guo M, et al. Tai chi and reduction of depressive symptoms for older adults: a meta-analysis of randomized trials. Geriatr Gerontol Int. 2013 Jan;13(1):3-12.Resumen external link opens in a new window

128. Bridle C, Spanjers K, Patel S, et al. Effect of exercise on depression severity in older people: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2012 Sep;201(3):180-5.Texto completo external link opens in a new windowResumen external link opens in a new window

129. Belvederi Murri M, Amore M, Menchetti M, et al; Safety and Efficacy of Exercise for Depression in Seniors (SEEDS) Study Group. Physical exercise for late-life major depression. Br J Psychiatry. 2015 Sep;207(3):235-42.Texto completo external link opens in a new windowResumen external link opens in a new window

130. Lam RW, Levitt AJ, Levitan RD, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2016 Jan;73(1):56-63.Resumen external link opens in a new window

131. Trivedi MH, Greer TL, Church TS, et al. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry. 2011 May;72(5):677-84.Resumen external link opens in a new window

132. Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane Database Syst Rev. 2013 Sep 12;(9):CD004366.Texto completo external link opens in a new windowResumen external link opens in a new window

133. Sukhato K, Lotrakul M, Dellow A, et al. Efficacy of home-based non-pharmacological interventions for treating depression: a systematic review and network meta-analysis of randomised controlled trials. BMJ Open. 2017 Jul 12;7(7):e014499.Texto completo external link opens in a new windowResumen external link opens in a new window

134. Catalan-Matamoros D, Gomez-Conesa A, Stubbs B, et al. Exercise improves depressive symptoms in older adults: an umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 2016 Oct 30;244:202-9.Resumen external link opens in a new window

135. Smith CA, Armour M, Lee MS, et al. Acupuncture for depression. Cochrane Database Syst Rev. 2018 Mar 4;(3):CD004046.Texto completo external link opens in a new windowResumen external link opens in a new window

136. Spek V, Nyklícek I, Smits N, et al. Internet-based cognitive behavioural therapy for subthreshold depression in people over 50 years old: a randomized controlled clinical trial. Psychol Med. 2007 Dec;37(12):1797-806.Resumen external link opens in a new window

137. Kaltenthaler E, Parry G, Beverley C, et al. Computerised cognitive-behavioural therapy for depression: systematic review. Br J Psychiatry. 2008 Sep;193(3):181-4.Texto completo external link opens in a new windowResumen external link opens in a new window

138. Alvarez LM, Sotres JF, Leon SO, et al. Computer program in the treatment for major depression and cognitive impairment in university students. Comp Human Behav. 2008 May;24(3):816-26.

139. Charova E, Dorstyn D, Tully P, et al. Web-based interventions for comorbid depression and chronic illness: a systematic review. J Telemed Telecare. 2015 Jun;21(4):189-201.Resumen external link opens in a new window

140. Karyotaki E, Riper H, Twisk J, et al. Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms: a meta-analysis of individual participant data. JAMA Psychiatry. 2017 Apr 1;74(4):351-9.Texto completo external link opens in a new windowResumen external link opens in a new window

141. Zhou T, Li X, Pei Y, et al. Internet-based cognitive behavioural therapy for subthreshold depression: a systematic review and meta-analysis. BMC Psychiatry. 2016 Oct 21;16(1):356.Texto completo external link opens in a new windowResumen external link opens in a new window

142. Warmerdam L, van Straten A, Twisk J, et al. Internet-based treatment for adults with depressive symptoms: randomized controlled trial. J Med Internet Res. 2008 Nov 20;10(4):e44.Texto completo external link opens in a new windowResumen external link opens in a new window

143. van Straten A, Cuijpers P, Smits N. Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trial. J Med Internet Res. 2008 Mar 25;10(1):e7.Resumen external link opens in a new window

144. Billings DW, Cook RF, Hendrickson A, Dove DC. A web-based approach to managing stress and mood disorders in the workforce. J Occup Environ Med. 2008 Aug;50(8):960-8.Resumen external link opens in a new window

145. Gartlehner G, Gaynes BN, Hansen RA, et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med. 2008 Nov 18;149(10):734-50.Texto completo external link opens in a new windowResumen external link opens in a new window

146. Gartlehner G, Thaler K, Hill S, et al. How should primary care doctors select which antidepressants to administer? Curr Psychiatry Rep. 20122 Aug;14(4):360-9.Resumen external link opens in a new window

147. Kolovos S, Kleiboer A, Cuijpers P. Effect of psychotherapy for depression on quality of life: meta-analysis. Br J Psychiatry. 2016 Dec;209(6):460-8.Texto completo external link opens in a new windowResumen external link opens in a new window

148. Cuijpers P, Koole SL, van Dijke A, et al. Psychotherapy for subclinical depression: meta-analysis. Br J Psychiatry. 2014 Oct;205(4):268-74.Texto completo external link opens in a new windowResumen external link opens in a new window

149. Casañas R, Catalán R, del Val JL, et al. Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial. BMC Psychiatry. 2012 Dec 18;12:230.Texto completo external link opens in a new windowResumen external link opens in a new window

150. Driessen E, Cuijpers P, de Maat SC, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis. Clin Psychol Rev. 2010 Feb;30(1):25-36.Resumen external link opens in a new window

151. den Boer PC, Wiersma D, Van den Bosch RJ. Why is self-help neglected in the treatment of emotional disorders? A meta-analysis. Psychol Med. 2004 Aug;34(6):959-71.Resumen external link opens in a new window

152. Pilkington K, Kirkwood G, Rampes H, et al. Yoga for depression: the research evidence. J Affect Disord. 2005 Dec;89(1-3):13-24.Resumen external link opens in a new window

153. Krogh J, Nordentoft M, Sterne JA, et al. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2011 Apr;72(4):529-38.Resumen external link opens in a new window

154. Morgan JA, Olagunju AT, Corrigan F, et al. Does ceasing exercise induce depressive symptoms? A systematic review of experimental trials including immunological and neurogenic markers. J Affect Disord. 2018 Jul;234:180-92.Resumen external link opens in a new window

155. Morres ID, Hatzigeorgiadis A, Stathi A, et al. Aerobic exercise for adult patients with major depressive disorder in mental health services: a systematic review and meta-analysis. Depress Anxiety. 2019 Jan;36(1):39-53.Texto completo external link opens in a new windowResumen external link opens in a new window

156. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000448.Texto completo external link opens in a new windowResumen external link opens in a new window

157. Apaydin EA, Maher AR, Shanman R, et al. A systematic review of St. John's wort for major depressive disorder. Syst Rev. 2016 Sep 2;5(1):148.Texto completo external link opens in a new windowResumen external link opens in a new window

158. Schulz V. Safety of St. John's Wort extract compared to synthetic antidepressants. Phytomedicine. 2006;13:199-204.Resumen external link opens in a new window

159. Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):118-27.Resumen external link opens in a new window

160. Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007 Nov;17(11):696-707.Resumen external link opens in a new window

161. Kronish IM, Hampsey M, Falzon L, et al. Personalized (N-of-1) trials for depression: a systematic review. J Clin Psychopharmacol. 2018 Jun;38(3):218-25.Resumen external link opens in a new window

162. Rush AJ, Trivedi MH, Stewart JW, et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011 Jul;168(7):689-701.Texto completo external link opens in a new windowResumen external link opens in a new window

163. Dold M, Kasper S. Evidence-based pharmacotherapy of treatment-resistant unipolar depression. Int J Psychiatry Clin Pract. 2017 Mar;21(1):13-23.Resumen external link opens in a new window

164. Henssler J, Bschor T, Baethge C. Combining antidepressants in acute treatment of depression: a meta-analysis of 38 studies including 4511 patients. Can J Psychiatry. 2016 Jan;61(1):29-43.Texto completo external link opens in a new windowResumen external link opens in a new window

165. Kessler D, Burns A, Tallon D, et al. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Health Technol Assess. 2018 Nov;22(63):1-136.Texto completo external link opens in a new windowResumen external link opens in a new window

166. Shulman KI, Herrmann N, Walker SE. Current place of monoamine oxidase inhibitors in the treatment of depression. CNS Drugs. 2013 Oct;27(10):789-97.Resumen external link opens in a new window

167. Strawbridge R, Carter B, Marwood L, et al. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis. Br J Psychiatry. 2019 Jan;214(1):42-51.Texto completo external link opens in a new windowResumen external link opens in a new window

168. Tiihonen J, Tanskanen A, Hoti F, et al. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiatry. 2017 Jul;4(7):547-53.Resumen external link opens in a new window

169. Spielmans GI, Berman MI, Linardatos E, et al. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013;10(3):e1001403.Texto completo external link opens in a new windowResumen external link opens in a new window

170. Philip NS, Carpenter LL, Tyrka AR, et al. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J Psychiatr Pract. 2008 Jan;14(1):34-44.Resumen external link opens in a new window

171. Tohen M, Case M, Trivedi MH, et al. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies. J Clin Psychiatry. 2010 Apr;71(4):451-62.Resumen external link opens in a new window

172. Mohamed S, Johnson GR, Chen P, et al. Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized clinical trial. JAMA. 2017 Jul 11;318(2):132-45.Resumen external link opens in a new window

173. Edwards SJ, Hamilton V, Nherera L, et al. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation. Health Technol Assess. 2013 Nov;17(54):1-190.Resumen external link opens in a new window

174. Thase ME, Hobart M, Augustine C, et al. EPA-0808 - efficacy and safety of adjunctive brexpiprazole (opc-34712) in major depressive disorder (MDD): a phase iii, randomized, placebo-controlled study. Eur Psychiatry. 2014;29(suppl 1):1.

175. Yoon S, Jeon SW, Ko YH, et al. Adjunctive brexpiprazole as a novel effective strategy for treating major depressive disorder: a systematic review and meta-analysis. J Clin Psychopharmacol. 2017 Feb;37(1):46-53.Resumen external link opens in a new window

176. Citrome L. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2015 Sep;69(9):978-97.Resumen external link opens in a new window

177. Hollinghurst S, Carroll FE, Abel A, et al. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial. Br J Psychiatry. 2014 Jan;204(1):69-76.Resumen external link opens in a new window

178. Ijaz S, Davies P, Williams CJ, et al. Psychological therapies for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2018 May 14;(5):CD010558.Texto completo external link opens in a new windowResumen external link opens in a new window

179. Kleeblatt J, Betzler F, Kilarski LL, et al. Efficacy of off-label augmentation in unipolar depression: a systematic review of the evidence. Eur Neuropsychopharmacol. 2017 May;27(5):423-41.Resumen external link opens in a new window

180. Chaudron LH. Complex challenges in treating depression during pregnancy. Am J Psychiatry. 2013 Jan;170(1):12-20.Texto completo external link opens in a new windowResumen external link opens in a new window

181. Lassen D, Ennis ZN, Damkier P, et al. First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):32-6.Texto completo external link opens in a new windowResumen external link opens in a new window

182. McAllister-Williams RH, Baldwin DS, Cantwell R, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol. 2017 May;31(5):519-52.Resumen external link opens in a new window

183. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006 Feb 9;354(6):579-87.Resumen external link opens in a new window

184. Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry. 2013 Apr;70(4):436-43.Resumen external link opens in a new window

185. Furu K, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015 Apr 17;350:h1798.Texto completo external link opens in a new windowResumen external link opens in a new window

186. Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014 Jun 19;370(25):2397-407.Texto completo external link opens in a new windowResumen external link opens in a new window

187. McDonagh MS, Matthews A, Phillipi C, et al. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis. Obstet Gynecol. 2014 Sep;124(3):526-34.Resumen external link opens in a new window

188. Bérard A, Zhao JP, Sheehy O. Sertraline use during pregnancy and the risk of major malformations. Am J Obstet Gynecol. 2015 Jun;212(6):795.e1-795.e12.Texto completo external link opens in a new windowResumen external link opens in a new window

189. Huybrechts KF, Bateman BT, Palmsten K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015 Jun 2;313(21):2142-51.Texto completo external link opens in a new windowResumen external link opens in a new window

190. Eke AC, Saccone G, Berghella V. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG. 2016 Nov;123(12):1900-7.Texto completo external link opens in a new windowResumen external link opens in a new window

191. Jarde A, Morais M, Kingston D, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry. 2016 Aug 1;73(8):826-37.Texto completo external link opens in a new windowResumen external link opens in a new window

192. Sanz EJ, De-las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005 Feb 5-11;365(9458):482-7.Resumen external link opens in a new window

193. Rai D, Lee BK, Dalman C, et al. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ. 2017 Jul 19;358:j2811.Texto completo external link opens in a new windowResumen external link opens in a new window

194. Kaplan YC, Keskin-Arslan E, Acar S, et al. Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies. Br J Clin Pharmacol. 2017 Dec;83(12):2798-806.Resumen external link opens in a new window

195. Brown HK, Hussain-Shamsy N, Lunsky Y, et al. The association between antenatal exposure to selective serotonin reuptake inhibitors and autism: a systematic review and meta-analysis. J Clin Psychiatry. 2017 Jan;78(1):e48-58.Resumen external link opens in a new window

196. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006 Feb 1;295(5):499-507.Texto completo external link opens in a new windowResumen external link opens in a new window

197. Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017 Feb 7;342:154-66.Resumen external link opens in a new window

198. Pompili M, Dominici G, Giordano G, et al. Electroconvulsive treatment during pregnancy: a systematic review. Expert Rev of Neurother. 2014 Dec;14(12):1377-90.Resumen external link opens in a new window

199. Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med. 2009 Feb;71(2):235-42.Resumen external link opens in a new window

200. van Ravesteyn LM, Lambregtse-van den Berg MP, Hoogendijk WJ, et al. Interventions to treat mental disorders during pregnancy: a systematic review and multiple treatment meta-analysis. PLoS One. 2017 Mar 30;12(3):e0173397.Texto completo external link opens in a new windowResumen external link opens in a new window

201. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA. 2019 Feb 12;321(6):580-7.Texto completo external link opens in a new windowResumen external link opens in a new window

202. Lee EW, Denison FC, Hor K, et al. Web-based interventions for prevention and treatment of perinatal mood disorders: a systematic review. BMC Pregnancy Childbirth. 2016 Feb 29;16:38.Texto completo external link opens in a new windowResumen external link opens in a new window

203. Maki PM, Kornstein SG, Joffe H, et al; Board of Trustees for The North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018 Oct;25(10):1069-85.Resumen external link opens in a new window

204. Rohan KJ, Meyerhoff J, Ho SY, et al. Outcomes one and two winters following cognitive-behavioral therapy or light therapy for seasonal affective disorder. Am J Psychiatry. 2016 Mar 1;173(3):244-51.Resumen external link opens in a new window

205. Agabio R, Trogu E, Pani PP. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Database Syst Rev. 2018 Apr 24;(4):CD008581.Texto completo external link opens in a new windowResumen external link opens in a new window

206. Hassan AN, Howe AS, Samokhvalov AV, et al. Management of mood and anxiety disorders in patients receiving opioid agonist therapy: review and meta-analysis. Am J Addict. 2017 Sep;26(6):551-63. Resumen external link opens in a new window

207. Dudas R, Malouf R, McCleery J, et al. Antidepressants for treating depression in dementia. Cochrane Database Syst Rev. 2018 Aug 31;(8):CD003944. Texto completo external link opens in a new windowResumen external link opens in a new window

208. Eshun-Wilson I, Siegfried N, Akena DH, et al. Antidepressants for depression in adults with HIV infection. Cochrane Database Syst Rev. 2018 Jan 22;(1):CD008525. Texto completo external link opens in a new windowResumen external link opens in a new window

209. Li M, Kennedy EB, Byrne N, et al. Management of depression in patients with cancer: a clinical practice guideline. J Oncol Pract. 2016 Aug;12(8):747-56.Texto completo external link opens in a new windowResumen external link opens in a new window

210. Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2018 Apr 23;(4):CD011006.Texto completo external link opens in a new windowResumen external link opens in a new window

211. Adli M, Baethge C, Heinz A, et al. Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):387-400.Resumen external link opens in a new window

212. Gregory RJ, Canning SS, Lee TW, et al. Cognitive bibliotherapy for depression: a meta-analysis. Prof Psychol Res Pract. 2004;35.

213. Holdsworth N, Paxton R. Managing anxiety and depression. London, U.K.: Mental Health Foundation; 1999.

214. Burns DD. Feeling good: the new mood therapy. New York, New York: Avon Books; 1999.

215. Anderson L, Lewis G, Araya R, et al. Self-help books for depression: how can practitioners and patients make the right choice? Br J Gen Pract. 2005 May;55(514):387-92.Texto completo external link opens in a new windowResumen external link opens in a new window

216. Schulz V. Safety of St. John's Wort extract compared to synthetic antidepressants. Phytomedicine. 2006 Feb;13(3):199-204.Resumen external link opens in a new window

217. Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):118-27.Resumen external link opens in a new window

218. Fornaro M. Beyond monoamines towards the development of novel antidepressants. Journal of Psychopathology. 2012;18:226-33.Texto completo external link opens in a new window

219. Connolly KR, Thase ME. Emerging drugs for major depressive disorder. Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26.Resumen external link opens in a new window

220. Menezes D, Laranjo L, Marmeleira J. Criterion-related validity of the short form of the international physical activity questionnaire in adults who are deaf. Disabil Health J. 2017 Jan;10(1):33-8.Resumen external link opens in a new window

221. Rucker JJ, Jelen LA, Flynn S, et al. Psychedelics in the treatment of unipolar mood disorders: a systematic review. J Psychopharmacol. 2016 Dec;30(12):1220-9.Resumen external link opens in a new window

222. Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry. 2019 May 21;176(6):428-38.Texto completo external link opens in a new windowResumen external link opens in a new window

223. Fedgchin M, Trivedi M, Daly EJ, et al. Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1). Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-30.Texto completo external link opens in a new windowResumen external link opens in a new window

224. Daly EJ, Trivedi MH, Janik A, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2019 Jun 5 [Epub ahead of print].Texto completo external link opens in a new windowResumen external link opens in a new window

225. van de Loo AJAE, Bervoets AC, Mooren L, et al. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study. Psychopharmacology (Berl). 2017 Nov;234(21):3175-83.Texto completo external link opens in a new windowResumen external link opens in a new window

226. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003 May;160(5):835-45.Resumen external link opens in a new window

227. Perera T, George MS, Grammer G, et al. The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016 May-Jun;9(3):336-46. Texto completo external link opens in a new windowResumen external link opens in a new window

228. Martin JLR, Barbanoj MJ, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev. 2002;(2):CD003493.Texto completo external link opens in a new windowResumen external link opens in a new window

229. Herrmann LLE. Transcranial magnetic stimulation. Psychiatry. 2009;8:130-4.

230. Allan CL, Herrmann LL, Ebmeier KP. Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology. 2011;64(3):163-9.Texto completo external link opens in a new windowResumen external link opens in a new window

231. Wasserman D, Rihmer Z, Rujescu D,et al. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 2012 Feb;27(2):129-41.Resumen external link opens in a new window

232. Berlim MT, Van den Eynde F, Daskalakis ZJ. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry. 2013 Feb;74(2):e122-9.Resumen external link opens in a new window

233. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct;3(4):187-99.Resumen external link opens in a new window

234. Felipe RM, Ferrão YA. Transcranial magnetic stimulation for treatment of major depression during pregnancy: a review. Trends Psychiatry Psychother. 2016 Oct-Dec;38(4):190-7.Texto completo external link opens in a new windowResumen external link opens in a new window

235. Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psychiatry. 2017 Feb 1;74(2):143-52.Resumen external link opens in a new window

236. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci. 2005 Mar;30(2):83-90.Texto completo external link opens in a new windowResumen external link opens in a new window

237. Lopez-Ibor JJ, Lopez-Ibor MI, Pastrana JI. Transcranial magnetic stimulation. Curr Opin Psychiatry. 2008 Nov;21(6):640-4.Resumen external link opens in a new window

238. Kohler O, Benros ME, Nordentoft M, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014 Dec 1;71(12):1381-91.Resumen external link opens in a new window

239. Grimm S, Bajbouj M. Efficacy of vagus nerve stimulation in the treatment of depression. Expert Rev Neurother. 2010 Jan;10(1):87-92.Resumen external link opens in a new window

240. Carpenter LL, Friehs GM, Tyrka AR, et al. Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. Med Health RI. 2006 Apr;89(4):137;140-1.Resumen external link opens in a new window

241. Howland RH. Vagus nerve stimulation for depression and other neuropsychiatric disorders. J Psychosoc Nurs Ment Health Serv. 2006 Sep;44(9):11-4.Resumen external link opens in a new window

242. Murphy JV, Patil A. Stimulation of the nervous system for the management of seizures: current and future developments. CNS Drugs. 2003;17(2):101-15.Resumen external link opens in a new window

243. Martin JL, Martín-Sánchez E. Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatry. 2012 Apr;27(3):147-55.Resumen external link opens in a new window

244. Bergfeld IO, Mantione M, Hoogendoorn ML, et al. Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2016 May 1;73(5):456-64.Resumen external link opens in a new window

245. Naesström M, Blomstedt P, Bodlund O. A systematic review of psychiatric indications for deep brain stimulation, with focus on major depressive and obsessive-compulsive disorder. Nord J Psychiatry. 2016 Oct;70(7):483-91.Resumen external link opens in a new window

246. Mosley PE, Marsh R, Carter A. Deep brain stimulation for depression: Scientific issues and future directions. Aust N Z J Psychiatry. 2015 Nov;49(11):967-78.Resumen external link opens in a new window

247. Brunoni AR, Moffa AH, Fregni F, et al. Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br J Psychiatry. 2016 Jun;208(6):522-31.Texto completo external link opens in a new windowResumen external link opens in a new window

248. Brunoni AR, Moffa AH, Sampaio-Junior B, et al. Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med. 2017 Jun 29;376(26):2523-33.Texto completo external link opens in a new windowResumen external link opens in a new window

249. Palm U, Hasan A, Strube W, et al. tDCS for the treatment of depression: a comprehensive review. Eur Arch Psychiatry Clin Neurosci. 2016 Dec;266(8):681-94.Resumen external link opens in a new window

250. Papakostas GI, Cooper-Kazaz R, Appelhof BC, et al. Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies. Int Clin Psychopharmacol. 2009 Jan;24(1):19-25.Resumen external link opens in a new window

251. Obrocea GVM. Thyroid hormone augmentation in treatment-refractory depression. Clin Psychopharmacol Neurosci. 2008;6(1):3-10.

252. Hardy SE. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother. 2009 Feb;7(1):34-59.Resumen external link opens in a new window

253. Cooper-Kazaz R, Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol. 2008 Aug;11(5):685-99.Resumen external link opens in a new window

254. Candy M, Jones L, Williams R, et al. Psychostimulants for depression. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006722.Texto completo external link opens in a new windowResumen external link opens in a new window

255. Sarris J, Murphy J, Mischoulon D, et al. Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry. 2016 Jun 1;173(6):575-87.Resumen external link opens in a new window

256. De Berardis D, Orsolini L, Serroni N, et al. A comprehensive review on the efficacy of S-adenosyl-L-methionine in major depressive disorder. CNS Neurol Disord Drug Targets. 2016;15(1):35-44.Resumen external link opens in a new window

257. Mocking RJ, Harmsen I, Assies J, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016 Mar 15;6:e756.Texto completo external link opens in a new windowResumen external link opens in a new window

258. Fernandes BS, Dean OM, Dodd S, et al. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. J Clin Psychiatry. 2016 Apr;77(4):e457-66.Resumen external link opens in a new window

259. Bedson E, Bell D, Carr D, et al. Folate augmentation of treatment-evaluation for depression (FolATED): randomised trial and economic evaluation. Health Technol Assess. 2014 Jul;18(48):vii-viii;1-159.Texto completo external link opens in a new windowResumen external link opens in a new window

260. Bot M, Brouwer IA, Roca M, et al. Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: the MooDFOOD randomized clinical trial. JAMA. 2019 Mar 5;321(9):858-68.Resumen external link opens in a new window

261. Caddy C, Amit BH, McCloud TL, et al. Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev. 2015 Sep 23;(9):CD011612.Texto completo external link opens in a new windowResumen external link opens in a new window

262. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017 Apr 1;74(4):399-405.Resumen external link opens in a new window

263. Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013 Oct;170(10):1134-42.Texto completo external link opens in a new windowResumen external link opens in a new window

264. Kraus C, Rabl U, Vanicek T, et al. Administration of ketamine for unipolar and bipolar depression. Int J Psychiatry Clin Pract. 2017 Mar;21(1):2-12.Resumen external link opens in a new window

265. Singh JB, Fedgchin M, Daly EJ, et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. 2016 Aug 1;173(8):816-26.Resumen external link opens in a new window

266. Short B, Fong J, Galvez V, et al. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018 Jan;5(1):65-78.Resumen external link opens in a new window

267. Covvey JR, Crawford AN, Lowe DK. Intravenous ketamine for treatment-resistant major depressive disorder. Ann Pharmacother. 2012 Jan;46(1):117-23.Resumen external link opens in a new window

268. Newport DJ, Carpenter LL, McDonald WM, et al; APA Council of Research Task Force on Novel Biomarkers and Treatments. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015 Oct;172(10):950-66.Texto completo external link opens in a new windowResumen external link opens in a new window

269. Nassan M, Nicholson WT, Elliott MA, et al. Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: a template for psychiatric precision medicine. Mayo Clin Proc. 2016 Jul;91(7):897-907.Resumen external link opens in a new window

270. Rosenblat JD, Lee Y, McIntyre RS. Does pharmacogenomic testing improve clinical outcomes for major depressive disorder? A systematic review of clinical trials and cost-effectiveness studies. J Clin Psychiatry. 2017 Jun;78(6):720-9.Resumen external link opens in a new window

271. Taylor MJ, Rudkin L, Bullemor-Day P, et al. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013 May 31;(5):CD003382.Resumen external link opens in a new window

272. Nurnberg HG, Hensley PL. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. CNS Spectr. 2003 Mar;8(3):194-202.Resumen external link opens in a new window

273. Demyttenaere K, Jaspers L. Review: bupropion and SSRI-induced side effects. J Psychopharmacol. 2008 Sep;22(7):792-804.Resumen external link opens in a new window

274. Ratheesh A, Davey C, Hetrick S, et al. A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder. Acta Psychiatr Scand. 2017 Apr;135(4):273-84. Resumen external link opens in a new window

275. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 2002 Nov;63(11):985-91.Resumen external link opens in a new window

276. Andrade C. Antidepressant-withdrawal mania: a critical review and synthesis of the literature. J Clin Psychiatry. 2004 Jul;65(7):987-93.Resumen external link opens in a new window

277. Ghaemi SN, Rosenquist KJ, Ko JY, et al. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004 Jan;161(1):163-5.Resumen external link opens in a new window

278. Möller HJ, Baldwin DS, Goodwin G, et al. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci. 2008 Aug;258(suppl 3):S3-23.Resumen external link opens in a new window

279. Carpenter DJ, Fong R, Kraus JE, et al. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials. J Clin Psychiatry. 2011 Nov;72(11):1503-14.Resumen external link opens in a new window

280. Ho SC, Chong HY, Chaiyakunapruk N, et al. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord. 2016 Mar 15;193:1-10.Resumen external link opens in a new window

281. Holvast F, Oude Voshaar RC, Wouters H, et al. Non-adherence to antidepressants among older patients with depression: a longitudinal cohort study in primary care. Fam Pract. 2019 Jan 25;36(1):12-20.Resumen external link opens in a new window

282. Dodd S, Mitchell PB, Bauer M, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. World J Biol Psychiatry. 2018 Aug;19(5):330-48. Resumen external link opens in a new window

283. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000 Jan 12;283(2):212-20.Resumen external link opens in a new window

284. Simon GE, Ralston JD, Savarino J, et al. Randomized trial of depression follow-up care by online messaging. J Gen Intern Med. 2011 Jul;26(7):698-704.Texto completo external link opens in a new windowResumen external link opens in a new window

285. Sirey JA, Banerjee S, Marino P, et al. Adherence to depression treatment in primary care: a randomized clinical trial. JAMA Psychiatry. 2017 Nov 1;74(11):1129-35.Resumen external link opens in a new window

286. Katon WJ, Schoenbaum M, Fan MY, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry. 2005 Dec;62(12):1313-20.Resumen external link opens in a new window

287. Koike AK, Unutzer J, Wells KB. Improving the care for depression in patients with comorbid medical illness. Am J Psychiatry. 2002 Oct;159(10):1738-45.Resumen external link opens in a new window

288. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002 Dec 11;288(22):2836-45.Resumen external link opens in a new window

289. Wells KB. The design of Partners in Care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol. 1999 Jan;34(1):20-9.Resumen external link opens in a new window

290. Soucy Chartier I, Provencher MD. Behavioural activation for depression: efficacy, effectiveness and dissemination. J Affect Disord. 2013 Mar 5;145(3):292-9.Resumen external link opens in a new window

291. Moritz S, Schilling L, Hauschildt M, et al. A randomized controlled trial of internet-based therapy in depression. Behav Res Ther. 2012 Aug;50(7-8):513-21.Resumen external link opens in a new window

292. Ebert DD, Donkin L, Andersson G, et al. Does internet-based guided-self-help for depression cause harm? An individual participant data meta-analysis on deterioration rates and its moderators in randomized controlled trials. Psychol Med. 2016 Oct;46(13):2679-93. Texto completo external link opens in a new windowResumen external link opens in a new window

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad